Double diabetes: A distinct high-risk group?
- PMID: 31373146
- DOI: 10.1111/dom.13848
Double diabetes: A distinct high-risk group?
Abstract
The term double diabetes (DD) has been used to refer to individuals with type 1 diabetes (T1D) who are overweight, have a family history of type 2 diabetes and/or clinical features of insulin resistance. Several pieces of evidence indicate that individuals who display features of DD are at higher risk of developing future diabetes complications, independently of average glucose control, measured as glycated haemoglobin (HbA1c) concentration. Given the increased prevalence of individuals with features of DD, pragmatic criteria are urgently required to identify and stratify this group, which will help with subsequent implementation of more effective personalized interventions. In this review, we discuss the potential criteria for the clinical identification of individuals with DD, highlighting the strengths and weaknesses of each definition. We also cover potential mechanisms of DD and how these contribute to increased risk of diabetes complications. Special emphasis is placed on the role of estimated glucose disposal rate (eGDR) in the diagnosis of DD, which can be easily incorporated into clinical practice and is predictive of adverse clinical outcome. In addition to the identification of individuals with DD, eGDR has potential utility in monitoring response to different interventions. T1D is a more heterogeneous condition than initially envisaged, and those with features of DD represent a subgroup at higher risk of complications. Pragmatic criteria for the diagnosis of individuals with DD will help with risk stratification, allowing a more personalized and targeted management strategy to improve outcome and quality of life in this population.
Keywords: double diabetes; estimated glucose disposal rate; metabolic syndrome; obesity; type 1 diabetes.
© 2019 John Wiley & Sons Ltd.
Similar articles
-
The association between overweight/obesity and double diabetes in adults with type 1 diabetes; a cross-sectional study.BMC Endocr Disord. 2021 Sep 16;21(1):187. doi: 10.1186/s12902-021-00851-1. BMC Endocr Disord. 2021. PMID: 34530819 Free PMC article.
-
Double diabetes-when type 1 diabetes meets type 2 diabetes: definition, pathogenesis and recognition.Cardiovasc Diabetol. 2024 Feb 10;23(1):62. doi: 10.1186/s12933-024-02145-x. Cardiovasc Diabetol. 2024. PMID: 38341550 Free PMC article. Review.
-
The Impact of Body Mass Index, Residual Beta Cell Function and Estimated Glucose Disposal Rate on the Development of Double Diabetes and Microvascular Complications in Patients With Type 1 Diabetes Mellitus.Cureus. 2023 Nov 17;15(11):e48979. doi: 10.7759/cureus.48979. eCollection 2023 Nov. Cureus. 2023. PMID: 38111445 Free PMC article.
-
Hemoglobin glycation index among adults with type 1 diabetes: Association with double diabetes features.World J Diabetes. 2025 Apr 15;16(4):100917. doi: 10.4239/wjd.v16.i4.100917. World J Diabetes. 2025. PMID: 40236850 Free PMC article.
-
Type 1 diabetes, metabolic syndrome and cardiovascular risk.Metabolism. 2014 Feb;63(2):181-7. doi: 10.1016/j.metabol.2013.10.002. Epub 2013 Oct 24. Metabolism. 2014. PMID: 24274980 Review.
Cited by
-
Predictive worth of estimated glucose disposal rate: evaluation in patients with non-ST-segment elevation acute coronary syndrome and non-diabetic patients after percutaneous coronary intervention.Diabetol Metab Syndr. 2022 Oct 6;14(1):145. doi: 10.1186/s13098-022-00915-9. Diabetol Metab Syndr. 2022. PMID: 36203208 Free PMC article.
-
Estimated glucose disposal rate demographics and clinical characteristics of young adults with type 1 diabetes mellitus: A cross-sectional pilot study.Diab Vasc Dis Res. 2020 May-Jun;17(5):1479164120952321. doi: 10.1177/1479164120952321. Diab Vasc Dis Res. 2020. PMID: 32883101 Free PMC article.
-
Magnesium Deficiency and Cardiometabolic Disease.Nutrients. 2023 May 17;15(10):2355. doi: 10.3390/nu15102355. Nutrients. 2023. PMID: 37242238 Free PMC article. Review.
-
Children and Adolescents With Hybrid Diabetes: A Management Conundrum.Endocr Pract. 2024 Jan;30(1):49-56. doi: 10.1016/j.eprac.2023.10.134. Epub 2023 Oct 31. Endocr Pract. 2024. PMID: 37913926 Free PMC article.
-
Asprosin: the potential player in combined double diabetes and hypothyroidism.Ir J Med Sci. 2024 Dec;193(6):2915-2921. doi: 10.1007/s11845-024-03758-7. Epub 2024 Jul 18. Ir J Med Sci. 2024. PMID: 39023819
References
REFERENCES
-
- Leahy JL. Pathogenesis of type 2 diabetes mellitus. Arch Med Res. 2005;36:197-209.
-
- Ahlqvist E, Storm P, Karajamaki A, et al. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol. 2018;6:361-369.
-
- Dennis JM, Shields BM, Henley WE, Jones AG, Hattersley AT. Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data. Lancet Diabetes Endocrinol. 2019;7:442-451.
-
- Teupe B, Bergis K. Epidemiological evidence for "double diabetes". Lancet. 1991;337:361-362.
-
- Libman IM, Becker DJ. Coexistence of type 1 and type 2 diabetes mellitus: "double" diabetes? Pediatr Diabetes. 2003;4:110-113.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical